Boxer Capital, LLC’s Trillium Therapeutics Inc Position
Does Boxer Capital, LLC own Trillium Therapeutics Inc (TREUR)? Not currently — the last reported position was 4.08M shares worth $33M in Q2 2020; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$33M
Q2 2020
Shares
4.08M
% of Portfolio
+1.45%
Quarters Held
2
position exited
Position History TREUR
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of TREUR.